DexCom, Inc.
DXCM
$72.33
-$5.51-7.08%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.34% | 16.19% | 23.05% | 25.78% | 24.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.34% | 16.19% | 23.05% | 25.78% | 24.49% |
| Cost of Revenue | 19.60% | 23.23% | 27.16% | 31.51% | 29.87% |
| Gross Profit | 6.52% | 12.21% | 20.74% | 22.62% | 21.55% |
| SG&A Expenses | 8.47% | 6.31% | 9.40% | 11.34% | 17.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.50% | 14.82% | 18.33% | 19.99% | 20.09% |
| Operating Income | 0.38% | 24.06% | 52.05% | 64.09% | 52.79% |
| Income Before Tax | -0.20% | 24.52% | 60.35% | 85.69% | 81.78% |
| Income Tax Expenses | -21.37% | -71.37% | -3.91% | 9.79% | 240.52% |
| Earnings from Continuing Operations | 6.41% | 80.58% | 86.55% | 118.56% | 58.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.41% | 80.58% | 86.55% | 118.56% | 58.70% |
| EBIT | 0.38% | 24.06% | 52.05% | 64.09% | 52.79% |
| EBITDA | 4.34% | 24.32% | 45.62% | 52.12% | 43.25% |
| EPS Basic | 4.25% | 78.78% | 85.80% | 119.82% | 60.18% |
| Normalized Basic EPS | -2.20% | 23.06% | 59.67% | 86.86% | 83.41% |
| EPS Diluted | 8.69% | 83.50% | 87.93% | 117.95% | 59.03% |
| Normalized Diluted EPS | 2.51% | 28.19% | 63.18% | 86.37% | 82.72% |
| Average Basic Shares Outstanding | 1.95% | 1.38% | 0.68% | -0.50% | -0.86% |
| Average Diluted Shares Outstanding | -2.50% | -2.53% | -1.50% | -0.04% | -0.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
